Dietary acrylamide and the risk of endometrial cancer: An Italian case-control study

Claudio Pelucchi, Carlotta Galeone, Eva Vanna Lorenza Negri, Cristina Bosetti, Diego Serraino, Maurizio Montella, Renato Talamini, Carlo La Vecchia

Research output: Contribution to journalArticle

Abstract

The role of dietary acrylamide on the risk of hormone-related, and specifically endometrial, cancers is debated. Epidemiological data are scanty. Thus, we examined the relation between acrylamide intake and endometrial cancer risk in a case-control study conducted between 1992 and 2006 in 3 Italian areas. Cases were 454 women with incident, histologically confirmed endometrial cancer. Controls were 908 age-matched women admitted to the same network of hospitals of cases for acute, non-neoplastic conditions. We calculated multivariate odds ratios (OR) and 95% confidence intervals (CI) using logistic regression models. The OR of endometrial cancer for increasing quintiles of dietary acrylamide, as compared to the lowest one, were 1.02 (95% CI: 0.67–1.54), 1.20 (95% CI: 0.80–1.80), 1.00 (95% CI: 0.65–1.54) and 1.17 (95% CI: 0.73–1.85). The OR for an increase of 10 μg/day of dietary acrylamide was 1.00 (95% CI: 0.91–1.10). In subgroup analyses, the ORs for high vs. low acrylamide intake were 1.28 (95% CI: 0.73–2.25) in never smokers and 1.14 (95% CI: 0.45–2.90) in ever smokers. Our data do not support an association between dietary acrylamide intake and endometrial cancer.

Original languageEnglish
Pages (from-to)187-192
Number of pages6
JournalNutrition and Cancer
DOIs
Publication statusPublished - 2016

Fingerprint

Acrylamide
Endometrial Neoplasms
Case-Control Studies
Confidence Intervals
Odds Ratio
Logistic Models
Hormones

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Oncology
  • Cancer Research

Cite this

Dietary acrylamide and the risk of endometrial cancer : An Italian case-control study. / Pelucchi, Claudio; Galeone, Carlotta; Negri, Eva Vanna Lorenza; Bosetti, Cristina; Serraino, Diego; Montella, Maurizio; Talamini, Renato; La Vecchia, Carlo.

In: Nutrition and Cancer, 2016, p. 187-192.

Research output: Contribution to journalArticle

Pelucchi, Claudio ; Galeone, Carlotta ; Negri, Eva Vanna Lorenza ; Bosetti, Cristina ; Serraino, Diego ; Montella, Maurizio ; Talamini, Renato ; La Vecchia, Carlo. / Dietary acrylamide and the risk of endometrial cancer : An Italian case-control study. In: Nutrition and Cancer. 2016 ; pp. 187-192.
@article{6ec7f0667b5a489fbe34d462b6b2db00,
title = "Dietary acrylamide and the risk of endometrial cancer: An Italian case-control study",
abstract = "The role of dietary acrylamide on the risk of hormone-related, and specifically endometrial, cancers is debated. Epidemiological data are scanty. Thus, we examined the relation between acrylamide intake and endometrial cancer risk in a case-control study conducted between 1992 and 2006 in 3 Italian areas. Cases were 454 women with incident, histologically confirmed endometrial cancer. Controls were 908 age-matched women admitted to the same network of hospitals of cases for acute, non-neoplastic conditions. We calculated multivariate odds ratios (OR) and 95{\%} confidence intervals (CI) using logistic regression models. The OR of endometrial cancer for increasing quintiles of dietary acrylamide, as compared to the lowest one, were 1.02 (95{\%} CI: 0.67–1.54), 1.20 (95{\%} CI: 0.80–1.80), 1.00 (95{\%} CI: 0.65–1.54) and 1.17 (95{\%} CI: 0.73–1.85). The OR for an increase of 10 μg/day of dietary acrylamide was 1.00 (95{\%} CI: 0.91–1.10). In subgroup analyses, the ORs for high vs. low acrylamide intake were 1.28 (95{\%} CI: 0.73–2.25) in never smokers and 1.14 (95{\%} CI: 0.45–2.90) in ever smokers. Our data do not support an association between dietary acrylamide intake and endometrial cancer.",
author = "Claudio Pelucchi and Carlotta Galeone and Negri, {Eva Vanna Lorenza} and Cristina Bosetti and Diego Serraino and Maurizio Montella and Renato Talamini and {La Vecchia}, Carlo",
year = "2016",
doi = "10.1080/01635581.2016.1142585",
language = "English",
pages = "187--192",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",

}

TY - JOUR

T1 - Dietary acrylamide and the risk of endometrial cancer

T2 - An Italian case-control study

AU - Pelucchi, Claudio

AU - Galeone, Carlotta

AU - Negri, Eva Vanna Lorenza

AU - Bosetti, Cristina

AU - Serraino, Diego

AU - Montella, Maurizio

AU - Talamini, Renato

AU - La Vecchia, Carlo

PY - 2016

Y1 - 2016

N2 - The role of dietary acrylamide on the risk of hormone-related, and specifically endometrial, cancers is debated. Epidemiological data are scanty. Thus, we examined the relation between acrylamide intake and endometrial cancer risk in a case-control study conducted between 1992 and 2006 in 3 Italian areas. Cases were 454 women with incident, histologically confirmed endometrial cancer. Controls were 908 age-matched women admitted to the same network of hospitals of cases for acute, non-neoplastic conditions. We calculated multivariate odds ratios (OR) and 95% confidence intervals (CI) using logistic regression models. The OR of endometrial cancer for increasing quintiles of dietary acrylamide, as compared to the lowest one, were 1.02 (95% CI: 0.67–1.54), 1.20 (95% CI: 0.80–1.80), 1.00 (95% CI: 0.65–1.54) and 1.17 (95% CI: 0.73–1.85). The OR for an increase of 10 μg/day of dietary acrylamide was 1.00 (95% CI: 0.91–1.10). In subgroup analyses, the ORs for high vs. low acrylamide intake were 1.28 (95% CI: 0.73–2.25) in never smokers and 1.14 (95% CI: 0.45–2.90) in ever smokers. Our data do not support an association between dietary acrylamide intake and endometrial cancer.

AB - The role of dietary acrylamide on the risk of hormone-related, and specifically endometrial, cancers is debated. Epidemiological data are scanty. Thus, we examined the relation between acrylamide intake and endometrial cancer risk in a case-control study conducted between 1992 and 2006 in 3 Italian areas. Cases were 454 women with incident, histologically confirmed endometrial cancer. Controls were 908 age-matched women admitted to the same network of hospitals of cases for acute, non-neoplastic conditions. We calculated multivariate odds ratios (OR) and 95% confidence intervals (CI) using logistic regression models. The OR of endometrial cancer for increasing quintiles of dietary acrylamide, as compared to the lowest one, were 1.02 (95% CI: 0.67–1.54), 1.20 (95% CI: 0.80–1.80), 1.00 (95% CI: 0.65–1.54) and 1.17 (95% CI: 0.73–1.85). The OR for an increase of 10 μg/day of dietary acrylamide was 1.00 (95% CI: 0.91–1.10). In subgroup analyses, the ORs for high vs. low acrylamide intake were 1.28 (95% CI: 0.73–2.25) in never smokers and 1.14 (95% CI: 0.45–2.90) in ever smokers. Our data do not support an association between dietary acrylamide intake and endometrial cancer.

UR - http://www.scopus.com/inward/record.url?scp=84959064943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959064943&partnerID=8YFLogxK

U2 - 10.1080/01635581.2016.1142585

DO - 10.1080/01635581.2016.1142585

M3 - Article

SP - 187

EP - 192

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

ER -